ARRY-797 - Pfizer
Investor Presentation (Array Biopharma) - Sep 25, 2012 - "ARRY-797 Provides Durable Pain Relief; Phase 2, 12-week study in ankylosing spondylitis patients who have inadequate response to continuous NSAIDs" 
P2 data • Pain
http://www.larvolonline.com/tlg/ccdb/ArrayBioPharmaInvestorPresentationSep252012.pdf
 
Sep 25, 2012